McKesson MCK Stock
McKesson Price Chart
McKesson MCK Financial and Trading Overview
| McKesson stock price | 696.87 USD |
| Previous Close | 391.25 USD |
| Open | 393.4 USD |
| Bid | 393 USD x 900 |
| Ask | 401 USD x 800 |
| Day's Range | 392.48 - 400.52 USD |
| 52 Week Range | 298.69 - 401.78 USD |
| Volume | 724.41K USD |
| Avg. Volume | 953.19K USD |
| Market Cap | 54.21B USD |
| Beta (5Y Monthly) | 0.588732 |
| PE Ratio (TTM) | 15.977236 |
| EPS (TTM) | 21.82 USD |
| Forward Dividend & Yield | 2.16 (0.54%) |
| Ex-Dividend Date | May 31, 2023 |
| 1y Target Est | 441.57 USD |
MCK Valuation Measures
| Enterprise Value | 56.06B USD |
| Trailing P/E | 15.977236 |
| Forward P/E | 13.260524 |
| PEG Ratio (5 yr expected) | 1.31 |
| Price/Sales (ttm) | 0.19592528 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.203 |
| Enterprise Value/EBITDA | 11.301 |
Trading Information
McKesson Stock Price History
| Beta (5Y Monthly) | 0.588732 |
| 52-Week Change | 33.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 401.78 USD |
| 52 Week Low | 298.69 USD |
| 50-Day Moving Average | 378.94 USD |
| 200-Day Moving Average | 368.37 USD |
MCK Share Statistics
| Avg. Volume (3 month) | 953.19K USD |
| Avg. Daily Volume (10-Days) | 727.16K USD |
| Shares Outstanding | 135.51M |
| Float | 133.08M |
| Short Ratio | 1.42 |
| % Held by Insiders | 0.10% |
| % Held by Institutions | 89.68% |
| Shares Short | 1.59M |
| Short % of Float | 1.33% |
| Short % of Shares Outstanding | 1.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.09 |
| Trailing Annual Dividend Yield | 0.53% |
| 5 Year Average Dividend Yield | 92.00% |
| Payout Ratio | 0.0834 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 1.28% |
| Operating Margin (ttm) | 1.60% |
| Gross Margin | 4.41% |
| EBITDA Margin | 1.79% |
Management Effectiveness
| Return on Assets (ttm) | 4.43% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 276.71B USD |
| Revenue Per Share (ttm) | 1961.1 USD |
| Quarterly Revenue Growth (yoy) | 4.20% |
| Gross Profit (ttm) | 12.36B USD |
| EBITDA | 4.96B USD |
| Net Income Avi to Common (ttm) | 3.56B USD |
| Diluted EPS (ttm) | 25.04 |
| Quarterly Earnings Growth (yoy) | 113.90% |
Balance Sheet
| Total Cash (mrq) | 4.68B USD |
| Total Cash Per Share (mrq) | 34.5 USD |
| Total Debt (mrq) | 7.31B USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.924 |
| Book Value Per Share (mrq) | -13.654 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.16B USD |
| Levered Free Cash Flow (ttm) | 5.25B USD |
Profile of McKesson
| Country | United States |
| State | TX |
| City | Irving |
| Address | 6555 State Highway 161 |
| ZIP | 75039 |
| Phone | 972 446 4800 |
| Website | https://www.mckesson.com |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 45000 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Q&A For McKesson Stock
What is a current MCK stock price?
McKesson MCK stock price today per share is 696.87 USD.
How to purchase McKesson stock?
You can buy MCK shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for McKesson?
The stock symbol or ticker of McKesson is MCK.
Which industry does the McKesson company belong to?
The McKesson industry is Medical Distribution.
How many shares does McKesson have in circulation?
The max supply of McKesson shares is 125.33M.
What is McKesson Price to Earnings Ratio (PE Ratio)?
McKesson PE Ratio is 31.93721400 now.
What was McKesson earnings per share over the trailing 12 months (TTM)?
McKesson EPS is 21.82 USD over the trailing 12 months.
Which sector does the McKesson company belong to?
The McKesson sector is Healthcare.
McKesson MCK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P 500 (Yahoo.com) GSPC | 5528.75 USD — |
+0.06
|
2.75B USD — | 5468.64 USD — | 5553.66 USD — | — - | 2.75B USD — |
| S&P 500 INDEX SPX | 5528.75 USD — |
+0.06
|
2.75B USD — | 5468.64 USD — | 5553.66 USD — | — - | 2.75B USD — |
| NYSE COMPOSITE (DJ) NYA | 18971.73 USD — |
+0.38
|
— — | 18822.43 USD — | 19030.68 USD — | — - | — — |
| Nasdaq US Benchmark Personal Ca NQUSB4520N | 1388.08 USD — |
-0.31
|
— — | 1384.49 USD — | 1397.52 USD — | — - | — — |
| Nasdaq US Price Setters Index NQPRCE | 2753.14 USD — |
-0.2
|
— — | 2743.11 USD — | 2771.41 USD — | — - | — — |
| Nasdaq US Large Cap Equity Risi NQERR | 1445.98 USD — |
<0.01
|
— — | 1438.94 USD — | 1456.48 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| NASDAQ US Broad Dividend Achiev DAA | 3610.13 USD — |
-0.09
|
— — | 3589.96 USD — | 3630.82 USD — | — - | — — |
| Nasdaq US Large Cap Personal Ca NQUSL4520EURN | 1361.08 EUR 1487.85 USD |
<0.01
|
— — | 1361.08 EUR 1487.84 USD | 1361.08 EUR 1487.84 USD | — - | — — |
| Nasdaq US Benchmark Personal Ca NQUSB4520CADN | 1252.08 CAD 929.12 USD |
<0.01
|
— — | 1252.08 CAD 929.12 USD | 1252.08 CAD 929.12 USD | — - | — — |
| Nasdaq Factor Family US Value I NQFFUSV | 1680.91 USD — |
+0.2
|
— — | 1672.35 USD — | 1693.03 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2750.27 USD — |
-0.09
|
— — | 2735.39 USD — | 2775.41 USD — | — - | — — |
| Nasdaq US Low Volatility Divide LVDA | 1246.36 USD — |
+0.04
|
— — | 1242.46 USD — | 1252.04 USD — | — - | — — |
| NASDAQ Global BuyBack Achievers DRBG | 2243.85 USD — |
+0.39
|
— — | 2234.88 USD — | 2255.96 USD — | — - | — — |
- {{ link.label }} {{link}}